Advancing Clinical Research.

ApoCell is an established service provider and recognized leader in clinical research with expertise on the identification and molecular characterization of rare circulating cells. Founded in 2004, the company provides standard and esoteric testing services in a CLIA certified laboratory. More than 80 pharmaceutical and biotechnology companies worldwide have accessed ApoCell’s expertise to identify and qualify biomarkers in blood, tissue, saliva and hair follicles to support over 120 clinical trials in multiple therapeutic areas. The company has a proven track record managing simple and complex clinical trials ranging from small proof-of-concept studies to large multi-center Phase 3 trials. ApoCell’s logistics department has experience coordinating with over 200 clinical sites worldwide to ensure proper collection, shipping, receiving and processing of patient samples.